Invitation One health symposium FOCUS on STEC - HUSEC One health symposium FOCUS on STEC - HUSEC 11 December 2014 / 10:00 - 17:00 / UMCG Groningen Shiga toxin-producing Escherichia coli (STEC) pose a serious public health concern because of its ability to cause outbreaks, hemorrhagic colitis, and hemolytic uremic syndrome (HUS). STEC causing HUS are designated as HUSEC or EHEC. EHEC are subtypes of STEC and became broadly visible in the public due to the large outbreak in 2011 in Germany. A multidisciplinary team of European researchers will inform you on the latest developments in the field of STEC – EHEC – HUSEC. Central topics will be modern diagnostics, clinical management, public health & environment as well as research. In 2013 a multidisciplinary studygroup, called STEC-ID-net, was implemented in the Netherlands in order to study STEC and EHEC microbiology, epidemiology and the clinical impact. The results of this study will be presented during this symposium. Our aim is to stimulate the interest of young investigators for this important one health topic. • For more information about the programme and registration: www.stecnet.nl • Registration fee for the meeting: € 75,00 per person • Requests for accreditation have been submitted to NVMM, NVK, NIV, VHIG Scientific Committee Alex W. Friedrich, UMCG Nicole van de Kar, Radboud UMC Mariska Petrignani, RIVM Eelco Franz, RIVM John W. A. Rossen, UMCG Mirjam Kooistra-Smid, Certe Key Note Lectures: •Flemming Scheutz, WHO Collaborating Centre for Reference and Research, SSI, Copenhagen (DK) •Stefano Morabito, Istituto Superiore di Sanità, Rome (IT) Conference convenor Alex Friedrich, UMCG, Groningen (NL) Confirmed speakers: Diagnostics •Theo Schuurs, Izore, Leeuwarden (NL) •Richard de Boer, Certe, Groningen (NL) •Annet Heuvelink, Gezondheidsdienst voor Dieren, Deventer (NL) Clinical management •Nicole van de Kar, Radboud UMC, Nijmegen (NL) •Valentina Gracchi, UMCG, Groningen (NL) •Kioa Wijnsma, Radboud UMC, Nijmegen (NL) Public health & environment •Eelco Franz, RIVM, Bilthoven (NL) •Toos Waegemaekers, RIVM, Bilthoven (NL) •Bavo Verhaegen, Ghent University, Ghent (BE) Research •Mithila Ferdous, UMCG, Groningen (NL) •Elena Volokhina, Radboud UMC, Nijmegen (NL) •Reinhard Würzner, Innsbruck Medical University, Innsbruck (AT)